Sunshine and Binghamton University enter research agreement for cancer compound

[News]

Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Research Foundation of the State University of New York (SUNY), acting for and on behalf of Binghamton University (Binghamton, NY).

More... (http://www.news-medical.net/news/20110121/Sunshine-and-Binghamton-University-enter-research-agreement-for-cancer-compound.aspx)